ASPERGES, ERIKA
 Distribuzione geografica
Continente #
NA - Nord America 1.769
AS - Asia 1.061
EU - Europa 889
SA - Sud America 203
Continente sconosciuto - Info sul continente non disponibili 82
AF - Africa 53
OC - Oceania 3
Totale 4.060
Nazione #
US - Stati Uniti d'America 1.695
SG - Singapore 324
IT - Italia 286
CN - Cina 249
VN - Vietnam 186
BR - Brasile 164
RU - Federazione Russa 158
HK - Hong Kong 118
DE - Germania 104
FR - Francia 69
IE - Irlanda 69
FI - Finlandia 59
BD - Bangladesh 49
GB - Regno Unito 42
IN - India 40
CA - Canada 35
ZA - Sudafrica 34
MX - Messico 24
PL - Polonia 23
AR - Argentina 21
NL - Olanda 15
SE - Svezia 15
IQ - Iraq 13
ES - Italia 12
ID - Indonesia 10
PK - Pakistan 10
TR - Turchia 10
JP - Giappone 9
CZ - Repubblica Ceca 7
UA - Ucraina 7
VE - Venezuela 6
AT - Austria 5
PH - Filippine 5
SA - Arabia Saudita 5
BE - Belgio 4
EC - Ecuador 4
KE - Kenya 4
LT - Lituania 4
MA - Marocco 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CO - Colombia 3
JM - Giamaica 3
JO - Giordania 3
LK - Sri Lanka 3
PA - Panama 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
BH - Bahrain 2
CH - Svizzera 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LV - Lettonia 2
MY - Malesia 2
NP - Nepal 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
HT - Haiti 1
IR - Iran 1
KW - Kuwait 1
LB - Libano 1
MT - Malta 1
MU - Mauritius 1
MZ - Mozambico 1
NG - Nigeria 1
NI - Nicaragua 1
PS - Palestinian Territory 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 3.979
Città #
Dallas 499
San Jose 205
Singapore 186
Ashburn 158
Hong Kong 116
Council Bluffs 95
Beijing 72
Chandler 71
Dublin 69
Ho Chi Minh City 67
Los Angeles 67
Milan 62
Munich 52
Hanoi 45
Lauterbourg 44
New York 38
Boardman 36
Moscow 32
Helsinki 31
Johannesburg 30
Turku 28
Pavia 27
Warsaw 22
Redondo Beach 21
São Paulo 20
Buffalo 17
Orem 17
Columbus 16
Shanghai 16
Chennai 15
Frankfurt am Main 14
Montreal 14
Santa Clara 14
Denver 13
Princeton 13
Toronto 13
Pescara 12
London 11
Nuremberg 11
Vicenza 11
Atlanta 10
Lawrence 10
Brooklyn 9
Mexico City 9
Rome 9
Seattle 9
Ann Arbor 8
Chicago 8
Da Nang 8
Paris 8
San Francisco 8
Tokyo 8
Turin 8
Amsterdam 7
Brescia 7
Düsseldorf 7
Phoenix 7
Poplar 7
Rio de Janeiro 7
Wilmington 7
Belo Horizonte 6
Houston 6
Medford 6
Stockholm 6
The Dalles 6
Biên Hòa 5
Boston 5
Curitiba 5
Falkenstein 5
Guangzhou 5
Naples 5
New Delhi 5
Pune 5
Augusta 4
Brussels 4
Cascina 4
Cinisello Balsamo 4
Corsico 4
Haiphong 4
Hải Dương 4
Lahore 4
Manchester 4
Motta Visconti 4
Nairobi 4
Olomouc 4
Osasco 4
Piscataway 4
Querétaro 4
Washington 4
Amman 3
Ankara 3
Baghdad 3
Baoding 3
Cleveland 3
Colombo 3
Dhaka 3
Erbil 3
Genoa 3
Go Vap 3
Hyderabad 3
Totale 2.628
Nome #
Which explanations do clinicians prefer? A comparative evaluation of XAI understandability and actionability in predicting the need for hospitalization 412
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 178
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 153
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 150
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 142
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 138
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 136
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 131
Emergency Department and Out-of-Hospital Emergency System (112—AREU 118) integrated response to Coronavirus Disease 2019 in a Northern Italy centre 126
Fungal Osteomyelitis: A Systematic Review of Reported Cases 122
A case of leprosy in a nonendemic country 114
Rapid response to COVID-19 outbreak in Northern Italy: how to convert a classic infectious disease ward into a COVID-19 response centre 112
Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort Study 105
Detection of the SARS-CoV-2 in different biologic specimens from positive patients with COVID-19, in Northern Italy 98
Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM 98
Immunity to SARS-CoV-2 up to 15 months after infection 92
Competing-risk analysis of coronavirus disease 2019 in-hospital mortality in a Northern Italian centre from SMAtteo COvid19 REgistry (SMACORE) 92
SARS Cov-2 infection in a renal-transplanted patient: A case report 88
Impact of Pneumococcal Urinary Antigen Testing in COVID-19 Patients: Outcomes from the San Matteo COVID-19 Registry (SMACORE) 81
Antibiotic Stewardship Based on Colonization with Multi-Drug-Resistant Bacteria in Liver Transplantation: A Narrative Review 80
Despite Vaccination: A Real-Life Experience of Severe and Life-Threatening COVID-19 in Vaccinated and Unvaccinated Patients 79
Gut Microbiota and B Cell Receptor (BCR) Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Is Biodiversity Correlated with Clinical Response or Immune-Related Adverse Event Occurrence? A Cross-Sectional Study 78
Gut Microbiota and B Cell Receptor (BCR) Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Is Biodiversity Correlated with Clinical Response or Immune-Related Adverse Event Occurrence? A Cross-Sectional Study 70
The Prognostic Role of Diagnostic Criteria for COVID-19-Associated Pulmonary Aspergillosis: A Cross-Sectional Retrospective Study 69
Culture negative endocarditis and the role of proper blood culture collection: results from a tertiary care Centre of Northern Italy 66
The possible role of gut microbiota and microbial translocation profiling during chemo-free treatment of lymphoid malignancies 66
The infection risk after transjugular intrahepatic portosystemic shunt: A multiple competing risk analysis from a tertiary care center 64
PK/PD and antiviral activity of anti-HCV therapy: is there still a role in the choice of treatment? 63
Response to the Letter to the Editor Regarding “Prognostic Significance of NLR and PLR in COVID-19: A Multi-Cohort Validation Study” 63
Mortality due to COVID-19 during the pandemic: A comparison of first, second and third SMAtteo COvid19 REgistry (SMACORE) 62
HBV and HDV: New Treatments on the Horizon 61
Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit 60
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort 59
Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit 59
Psychological Support in a COVID-19 Hospital: A Community Case Study 56
Use of ICD-9-CM coding for identifying antibiotic prescriptions during hospitalization: a Delphi consensus model 53
Prognostic Significance of NLR and PLR in COVID-19: A Multi-Cohort Validation Study 50
Use of isavuconazole in critically ill patients in intensive care units: A prospective, observational, multicentre, cohort study 42
Minimum Inhibitory Concentration Increase in Clostridioides difficile Isolates from Patients with Recurrence: Results from a Retrospective Single-Centre Cohort Study 37
null 37
Performance of existing definitions and tests for the diagnosis of invasive fungal diseases other than invasive candidiasis and invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis 30
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 27
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG 26
Cefiderocol therapy among immunocompromised adult patients: a descriptive analysis from a prospective, multicentre cohort study 26
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, non-neutropenic, adult patients: An update including COVID-19 data 22
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis 20
Compassionate use of remdesivir for patients with severe Covid-19 19
A Case Report of Disseminated Histoplasmosis in AIDS Diagnosed Through Peripheral Blood Smear 17
Mortality of Pneumocystis jirovecii pneumonia in intensive care units: a post-hoc analysis of an international multicenter study by ESGCIP and EFISG 14
Aspergillus spp. in Non-Cystic Fibrosis Bronchiectasis: Clinical Phenotypes, Molecular Endotypes, and Practical Management—A Narrative Review 7
Seven versus fourteen days for resistant bloodstream infections: what do we actually know? A scoping review 6
QuantiFERON-TB gold plus in people living with HIV: independence from CD4+ T-cell counts in a low TB-burden setting 4
Totale 4.060
Categoria #
all - tutte 18.622
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.622


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202274 0 5 5 1 3 4 3 4 3 5 7 34
2022/2023217 16 19 2 18 12 21 0 6 78 1 40 4
2023/2024199 14 20 6 6 39 37 4 6 6 10 26 25
2024/2025841 12 32 11 32 19 40 137 45 209 61 84 159
2025/20262.537 135 112 529 262 319 90 379 145 232 128 103 103
2026/2027138 51 87 0 0 0 0 0 0 0 0 0 0
Totale 4.060